Details of Protein
| General Information of Protein (ID: PRT00778) | |||||
|---|---|---|---|---|---|
| Name | Solute carrier family 7 member 9 (SLC7A9) | ||||
| Synonyms |
Click to Show/Hide Synonyms of This Protein
b(0,+)AT1; Glycoprotein-associated amino acid transporter b0,+AT1; b(0,+)-type amino acid transporter 1; SLC7A9; BAT1
|
||||
| Gene Name | SLC7A9 | Gene ID | |||
| UniProt ID | |||||
| Family | Amino acid/polyamine transporter (AAPT) | ||||
| TC Number | TC: 2.A.3.8.19 (Click to Show/Hide the Complete TC Tree) | ||||
| Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
| Sequence |
MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTE
AVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVI KPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIF TAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNY ITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYP ASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGI IATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLI SVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVV PPEEDPE |
||||
| Structure | |||||
| Function | Involved in the high-affinity, sodium-independent transport of cystine and neutral and dibasic amino acids (system b(0,+)-like activity). Thought to be responsible for the high-affinity reabsorption of cystine in the kidney tubule. | ||||
| Regulatory Network | |||||
| Full List of Metabolite(s) Regulated by This Protein | ||||||
|---|---|---|---|---|---|---|
| Organic acids and derivatives | ||||||
| Cystine | Click to Show/Hide the Full List of Regulating Pair(s): 8 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation ( N227D) of SLC7A9 | |||||
| Induced Change | Cystine concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Nephropathic cystinosis [ICD-11: 5C60] | |||||
| Details | It is reported that mutation ( N227D) of SLC7A9 leads to the decrease of cystine levels compared with control group. | |||||
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (1105delA; W69stop) of SLC7A9 | |||||
| Induced Change | Cystine concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Nephropathic cystinosis [ICD-11: 5C60] | |||||
| Details | It is reported that mutation (1105delA; W69stop) of SLC7A9 leads to the decrease of cystine levels compared with control group. | |||||
| Regulating Pair (3) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (G195R) of SLC7A9 | |||||
| Induced Change | Cystine concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Nephropathic cystinosis [ICD-11: 5C60] | |||||
| Details | It is reported that mutation (G195R) of SLC7A9 leads to the decrease of cystine levels compared with control group. | |||||
| Regulating Pair (4) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (L223M) of SLC7A9 | |||||
| Induced Change | Cystine concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Nephropathic cystinosis [ICD-11: 5C60] | |||||
| Details | It is reported that mutation (L223M) of SLC7A9 leads to the decrease of cystine levels compared with control group. | |||||
| Regulating Pair (5) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (P482L) of SLC7A9 | |||||
| Induced Change | Cystine concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Nephropathic cystinosis [ICD-11: 5C60] | |||||
| Details | It is reported that mutation (P482L) of SLC7A9 leads to the decrease of cystine levels compared with control group. | |||||
| Regulating Pair (6) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (R333Q) of SLC7A9 | |||||
| Induced Change | Cystine concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Nephropathic cystinosis [ICD-11: 5C60] | |||||
| Details | It is reported that mutation (R333Q) of SLC7A9 leads to the decrease of cystine levels compared with control group. | |||||
| Regulating Pair (7) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (R333W) of SLC7A9 | |||||
| Induced Change | Cystine concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Nephropathic cystinosis [ICD-11: 5C60] | |||||
| Details | It is reported that mutation (R333W) of SLC7A9 leads to the decrease of cystine levels compared with control group. | |||||
| Regulating Pair (8) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (V142A; L223M) of SLC7A9 | |||||
| Induced Change | Cystine concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Nephropathic cystinosis [ICD-11: 5C60] | |||||
| Details | It is reported that mutation (V142A and L223M) of SLC7A9 leads to the decrease of cystine levels compared with control group. | |||||
| References | |||||
|---|---|---|---|---|---|
| 1 | A novel missense mutation of SLC7A9 frequent in Japanese cystinuria cases affecting the C-terminus of the transporter. Kidney Int. 2006 Apr;69(7):1198-206. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.

